Author:
Korell Julia,Stamp Lisa K.,Barclay Murray L.,Dalrymple Judith M.,Drake Jill,Zhang Mei,Duffull Stephen B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Morgan C, Lunt M, Brightwell H, et al. Contribution of patient related differences to multidrug resistance in rheumatoid arthritis. Ann Rheum Dis. 2003;62(1):15–9.
2. Angelis-Stoforidis P, Vajda F, Christophidis N. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis. Clin Exp Rheumatol. 1999;17(3):313–20.
3. Dervieux T, Furst D, Lein D, et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004;50(9):2766–74.
4. Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res. 2003;63(17):5538–43.
5. Zeng H, Chen Z, Belinsky M, et al. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1. Cancer Res. 2001;61(19):7225–32.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献